ALAINA BURRAN: Open Payments
NPI 1407143852 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 23 payments from 11 companies in 2025. Trend: 2023 $526 · 2024 $562 · 2025 $557
Food & beverage: $492Education: $65
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $211 |
| Janssen Biotech, Inc. | 3 | $109 |
| Amgen Inc. | 3 | $48 |
| ABBVIE INC. | 2 | $37 |
| Boston Scientific Corporation | 1 | $29 |
| LEO Pharma Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $27 |
| UCB, Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: DUPIXENT, TREMFYA, OTEZLA, General - Pain Management, ANZUPGO, EBGLYSS, Bimzelx, SKYRIZI.
Industry payments across GA — which companies pay providers there.
